|
Study
|
Device
|
Number
Treated
|
Mean
Pre HIFU
PSA(ng/ml)
|
Gleason
Score
|
Stage
|
Median
Follow up
(months)
|
Negative
biopsy
after HIFU |
|
Thuroff 2003
|
Ab
|
402
|
10.9
|
2-4 (13.2%)
5-7 (77.5%)
8-10 (9.3%)
|
T1-2
|
13
|
87.2%
|
|
Uchida 2006
|
Son
|
63
|
11.2 |
2-4 (21%)
5-7 (73%)
8-10 (15%)
|
T1-2
|
23.3
|
87%
|
Crouzet
2010
|
Ab
|
803
|
9.1
|
<=6(63.5)
7 (30.1)
>=8(6%)
|
T1-2
|
42
|
85%
|